The market for osteoarthritis therapeutics is expected to grow at a CAGR of around 7.7% from 2020 to 2027 and expected to reach the market value of around US$ 12.5 Bn by 2027.
Osteoarthritis (OR) is a form of arthritis that occurs when the protective cartilage that cushions the ends of bones wears down over time. Moreover, osteoarthritis can damage any joint but it mostly affects the joints including hands, knees, hips, and spine. The major cause of Osteoarthritis is old age, injury, or obesity. There are five stages of osteoarthritis in general including Stage 0, Stage 1 (Minor), Stage 2 (Mild), Stage 3 (Moderate), and Stage 4 (Severe). Some of the major symptoms of osteoarthritis include increased swelling and inflammation, increased pain, decreased range of motion, and joint instability.
Market Dynamics
The significant adoption of pain medications along with the increasing disposable income is driving the market growth. The increasing prevalence of osteoarthritis due to changing lifestyles and the increasing geriatric population is bolstering the market growth. The growing population susceptibility to osteoarthritis and the rising number of sports injuries across the globe is further bolstering the market value. Furthermore, personalized medicines for osteoarthritis and expected demand in emerging markets are the factors projected to create potential opportunities over the forecast timeframe from 2020 to 2027.
On the other side, the risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and commercialization of alternatives in the market are the factors likely to limit the growth to an extent over the forecast timeframe from 2020 to 2027.
Instance of Global Osteoarthritis Therapeutics Market
Prescription Drugs accounted for the maximum revenue share in the global osteoarthritis therapeutics market
Based on purchasing patterns, prescription drugs are the leading segment in the global osteoarthritis therapeutics market, and the segment is also anticipated to maintain its dominance over the forecast period from 2020 to 2027. Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) are prescribed for treating pain.
Europe is having potential revenue share in the Osteoarthritis Therapeutics Market
In 2019, Europe has registered a maximum share in terms of revenue on account of the presence of a huge geriatric and obese population base in the regional market. Germany, UK, France are the major contributors to the regional market value. The presence of major players in the region is additionally bolstering the regional market value. According to an article published by Oxford University Press, the most common type of arthritis, OA has affected more than 40 million people across Europe in 2014 and has a lifetime risk of 45% for knee OA and 25% for hip OA. Europe has a strongly aging population and prevalence of obesity which is supporting the regional market value. The Europe region is followed by North America in the Osteoarthritis Therapeutics Market. The major economies of the region including the US and Canada are the major contributors to the regional market value. Moreover, the Asia Pacific along with its developing economies is estimated to experience the fastest growth with maximum CAGR (%) during the forecast period.
Key Market Players
The players profiled in the report include Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and others.
Market Segmentation
Market By Drug Type
Viscosupplementation Agents
Nonsteroidal Anti-inflammatory Drugs
- Naproxen
- Aspirin
- Diclofenac
- Ibuprofen
- Other NSAIDs
Analgesics
Corticosteroids
Market By Anatomy
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis
Market By Route of Administration
Parenteral Route
Topical Route
Oral Route
Market By Purchasing Pattern
Prescription Drugs
Over-the-Counter Drugs
Market By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Osteoarthritis Therapeutics
1.1. Definition and Scope
1.1.1. Definition of Osteoarthritis Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Osteoarthritis Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Osteoarthritis Therapeutics Market By Drug Type
1.2.3. Osteoarthritis Therapeutics Market By Anatomy
1.2.4. Osteoarthritis Therapeutics Market By Route of Administration
1.2.5. Osteoarthritis Therapeutics Market By Purchasing Pattern
1.2.6. Osteoarthritis Therapeutics Market By Distribution Channel
1.2.7. Osteoarthritis Therapeutics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Cost Structure Analysis
3.5.1. Price Trend of Key Raw Materials
3.5.2. Raw Material Suppliers
3.5.3. Proportion of Manufacturing Cost Structure
3.5.3.1. Raw Material
3.5.3.2. Labor Cost
3.5.3.3. Manufacturing Expense
3.6. Regulatory Compliance
3.7. Competitive Landscape, 2019
3.7.1. Player Positioning Analysis
3.7.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Osteoarthritis Therapeutics Market By Drug Type
4.1. Introduction
4.2. Osteoarthritis Therapeutics Revenue By Drug Type
4.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast, By Drug Type, 2016-2027
4.2.2. Viscosupplementation Agents
4.2.2.1. Viscosupplementation Agents Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Nonsteroidal Anti-inflammatory Drugs
4.2.3.1. Nonsteroidal Anti-inflammatory Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.1. Naproxen
4.2.3.1.1.1. Naproxen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.2. Aspirin
4.2.3.1.2.1. Aspirin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.3. Diclofenac
4.2.3.1.3.1. Diclofenac Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.4. Ibuprofen
4.2.3.1.4.1. Ibuprofen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.1.5. Other NSAIDs
4.2.3.1.5.1. Other NSAIDs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Analgesics
4.2.4.1. Analgesics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.1. Duloxetine
4.2.4.1.1.1. Duloxetine Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4.1.2. Acetaminophen
4.2.4.1.2.1. Acetaminophen Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Corticosteroids
4.2.5.1. Corticosteroids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Osteoarthritis Therapeutics Market Revenue By Anatomy
5.1. Introduction
5.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Anatomy
5.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
5.2.2. Knee Osteoarthritis
5.2.2.1. Knee Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Hip Osteoarthritis
5.2.3.1. Hip Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Hand Osteoarthritis
5.2.4.1. Hand Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Small Joint Osteoarthritis
5.2.5.1. Small Joint Osteoarthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Osteoarthritis Therapeutics Market By Route of Administration
6.1. Introduction
6.2. Osteoarthritis Therapeutics Revenue (US$ Mn) By Route of Administration
6.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
6.2.2. Parenteral Route
6.2.2.1. Parenteral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Topical Route
6.2.3.1. Topical Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Oral Route
6.2.4.1. Oral Route Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Osteoarthritis Therapeutics Market By Purchasing Pattern
7.1. Introduction
7.2. Osteoarthritis Therapeutics Revenue (US$) By Purchasing Pattern
7.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
7.3. Prescription Drugs
7.3.1. Prescription Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Over-the-Counter Drugs
7.4.1. Over-the-Counter Drugs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. Osteoarthritis Therapeutics Market By Distribution Channel
8.1. Introduction
8.2. Osteoarthritis Therapeutics Revenue (US$) By Distribution Channel
8.2.1. Osteoarthritis Therapeutics Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 - 2027
8.3. Hospital Pharmacies
8.3.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.4. Retail Pharmacies
8.4.1. Retail Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
8.5. Online Pharmacies
8.5.1. Online Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 9. North America Osteoarthritis Therapeutics Market By Country
9.1. North America Osteoarthritis Therapeutics Overview
9.2. U.S.
9.2.1. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.2.2. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.2.3. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.2.4. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.2.5. U.S. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.3. Canada
9.3.1. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
9.3.2. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
9.3.3. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
9.3.4. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
9.3.5. Canada Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
9.4. North America PEST Analysis
CHAPTER 10. Europe Osteoarthritis Therapeutics Market By Country
10.1. Europe Osteoarthritis Therapeutics Market Overview
10.2. U.K.
10.2.1. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.2.2. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.2.3. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.2.4. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.2.5. U.K. Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.3. Germany
10.3.1. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.3.2. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.3.3. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.3.4. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.3.5. Germany Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.4. France
10.4.1. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.4.2. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.4.3. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.4.4. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.4.5. France Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.5. Spain
10.5.1. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.5.2. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.5.3. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.5.4. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.5.5. Spain Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.6. Rest of Europe
10.6.1. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016-2027
10.6.2. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016-2027
10.6.3. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016-2027
10.6.4. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016-2027
10.6.5. Rest of Europe Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016-2027
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Osteoarthritis Therapeutics Market By Country
11.1. Asia Pacific Osteoarthritis Therapeutics Market Overview
11.2. China
11.2.1. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.2.2. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.2.3. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.2.4. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.2.5. China Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.3. Japan
11.3.1. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.3.2. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.3.3. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.3.4. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.3.5. Japan Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4. India
11.4.1. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.4.2. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.4.3. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.4.4. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.4.5. India Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.5. Australia
11.5.1. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.5.2. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.5.3. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.5.4. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.5.5. Australia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.6. South Korea
11.6.1. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.6.2. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.6.3. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.6.4. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.6.5. South Korea Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
11.7.2. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
11.7.3. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
11.7.4. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
11.7.5. Rest of Asia-Pacific Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Osteoarthritis Therapeutics Market By Country
12.1. Latin America Osteoarthritis Therapeutics Market Overview
12.2. Brazil
12.2.1. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.2.2. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.2.3. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.2.4. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.2.5. Brazil Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.3. Mexico
12.3.1. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.3.2. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.3.3. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.3.4. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.3.5. Mexico Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
12.4. Rest of Latin America
12.4.1. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
12.4.2. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
12.4.3. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
12.4.4. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
12.4.5. Rest of Latin America Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 13. Middle East & Africa Osteoarthritis Therapeutics Market By Country
13.1. Middle East & Africa Osteoarthritis Therapeutics Market Overview
13.2. Saudi Arabia
13.2.1. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.2.2. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.2.3. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.2.4. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.2.5. Saudi Arabia Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.3. UAE
13.3.1. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.3.2. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.3.3. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.3.4. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.3.5. UAE Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Drug Type, 2016 - 2027
13.4.2. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Anatomy, 2016 - 2027
13.4.3. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Route of Administration, 2016 - 2027
13.4.4. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Purchasing Pattern, 2016 - 2027
13.4.5. Rest of Middle East & Africa Osteoarthritis Therapeutics Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
CHAPTER 14. Player Analysis Of Osteoarthritis Therapeutics
14.1. Osteoarthritis Therapeutics Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Osteoarthritis Therapeutics Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott Laboratories
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Mn), 2019
15.1.3.2. Abbott Laboratories 2019 Osteoarthritis Therapeutics Business Regional Distribution
15.1.4. Product/ Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Anika Therapeutics Inc.
15.3. Bayer Aktiengesellschaft
15.4. Eli Lilly Company
15.5. Flexion Therapeutics Inc.
15.6. GlaxoSmithKline Plc
15.7. Horizon Therapeutics Plc
15.8. Johnson & Johnson Inc.
15.9. Novartis AG
15.10. Pfizer Inc.
15.11. Sanofi S.A
15.12. Others
